Skip to main content
LONA
NASDAQ Life Sciences

LeonaBio Discloses Highly Dilutive Private Placement, More Than Doubling Shares Outstanding

KI-Analyse von Wiseek
Stimmung info
Negativ
Wichtigkeit info
9
Preis
$6.01
Marktkapitalisierung
$56.733M
52W Tief
$3.6
52W Hoch
$59
Market data snapshot near publication time

summarizeZusammenfassung

This Schedule 13D/A filing by Perceptive Advisors reveals a substantial private placement by LeonaBio, Inc., where 5,356,547 new shares were issued. This issuance represents a 135% increase in the company's outstanding shares, moving from approximately 3.9 million to 9.3 million shares. While the capital raised from this offering provides a financial runway, the extreme dilution is a significant negative for current shareholders, as it substantially reduces the per-share value of their holdings. Perceptive Advisors' ownership percentage has been adjusted to 19.99% as a result of this increased share count, not due to any sale of their holdings.


check_boxSchlusselereignisse

  • Significant Share Dilution

    LeonaBio issued 5,356,547 new shares in a private placement, increasing total outstanding shares by 135% to 9,300,434.

  • Major Capital Raise

    The private placement provided substantial capital to the company, though at the cost of significant dilution for existing shareholders.

  • Perceptive Advisors' Stake Adjusted

    Perceptive Advisors' beneficial ownership percentage was adjusted to 19.99% due to the increased share count, not from any sale of their shares.


auto_awesomeAnalyse

This Schedule 13D/A filing by Perceptive Advisors reveals a substantial private placement by LeonaBio, Inc., where 5,356,547 new shares were issued. This issuance represents a 135% increase in the company's outstanding shares, moving from approximately 3.9 million to 9.3 million shares. While the capital raised from this offering provides a financial runway, the extreme dilution is a significant negative for current shareholders, as it substantially reduces the per-share value of their holdings. Perceptive Advisors' ownership percentage has been adjusted to 19.99% as a result of this increased share count, not due to any sale of their holdings.

Zum Zeitpunkt dieser Einreichung wurde LONA bei 6,01 $ gehandelt an der NASDAQ im Sektor Life Sciences, bei einer Marktkapitalisierung von rund 56,7 Mio. $. Die 52-Wochen-Handelsspanne lag zwischen 3,60 $ und 59,00 $. Diese Einreichung wurde mit negativer Marktstimmung und einem Wichtigkeitsscore von 9 von 10 bewertet.

descriptionHaupt-SEC-Einreichung ansehen

show_chartPreisdiagramm

Diesen Artikel teilen

Copied!

feed LONA - Neueste Einblicke

LONA
Apr 01, 2026, 9:30 PM EDT
Filing Type: 424B3
Importance Score:
8
LONA
Apr 01, 2026, 9:30 PM EDT
Filing Type: 424B3
Importance Score:
7
LONA
Mar 31, 2026, 5:07 PM EDT
Filing Type: S-1/A
Importance Score:
8
LONA
Mar 31, 2026, 4:59 PM EDT
Filing Type: S-1/A
Importance Score:
8
LONA
Mar 31, 2026, 4:11 PM EDT
Filing Type: 10-K
Importance Score:
9
LONA
Mar 31, 2026, 2:20 PM EDT
Filing Type: 8-K/A
Importance Score:
8
LONA
Mar 26, 2026, 5:10 PM EDT
Filing Type: 8-K
Importance Score:
9
LONA
Mar 26, 2026, 5:10 PM EDT
Source: GlobeNewswire
Importance Score:
9
LONA
Mar 19, 2026, 4:50 PM EDT
Filing Type: 8-K
Importance Score:
9
LONA
Feb 23, 2026, 4:05 PM EST
Filing Type: DEF 14A
Importance Score:
9